Margin width is not predictive of residual disease on re-excision in breast-conserving therapy

Journal of Surgical Oncology

Volumn 109, Issue 6, 2014, Pages 507-508

  O'Brien, Julie ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SIZE; EXCISION; HUMAN; MINIMAL RESIDUAL DISEASE; NOTE; PARTIAL MASTECTOMY; PRIMARY TUMOR; PRIORITY JOURNAL; REEXCISION; TUMOR INVASION;

BREAST; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; REOPERATION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84898791022     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23565     Document Type: Note

References (6)

1. Hadzikadic Gusic L, McGuire KP, Ozmen T, et al.: Margin width is not predictive of residual disease on re-excision in breast conserving therapy. J Surg Oncol 2014; 109: 426-430.
2. Holland R, Veling SH, Mravunac M, et al.: Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56: 979-990.
3. Houssami N, Macaskill P, Marinovich ML, et al.: Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010; 46: 3219-3232.
4. Houssami N, Macaskill P, Marinovich L, et al.: The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 2014; 21: 717-730.
5. Pilewskie M, Ho A, Orell E, et al.: Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Ann Surg Oncol 2014; 21: 1209-1214.
6. Moran MS, Schnitt S, Giuliano AE, et al.: SSO-ASTRO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in stage I and II invasive breast cancer. Ann Surg Oncol 2014. (in press).